Charles River Laboratories Announces Third-Quarter 2026 Results

Charles River Laboratories Q3 EPS rises to $6.86 Charles River Laboratories’ third-quarter 2026

Charles River Laboratories Q3 revenue beats estimates, lifts 2026 outlook

Charles River reported third-quarter 2026 revenue of $982.7 million and diluted earnings per share of $6.86, including a $5.06-per-share benefit from reversing acquired tax reserves. Organic revenue grew 4.7%, while adjusted diluted EPS rose 27.2% year over year to $3.09. The company raised its 202…

WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) revealed a profit for its third quarter that Increases, from last yearThe company's bottom line came in at $333.067 million, or $6.86 per share. This compares with $54.422 million, or $1.10 per share, last year.Excluding it…